# Azathioprine

## Asazipam 50mg

| TAH Drug Code      | [OASZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OASZ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjuvant therapy for preventing rejection in kidney transplant surgery, systemic lupus erythematosus, severe rheumatoid arthritis, acute and chronic leukemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Organ transplantation: Adults and children - up to 5 mg/kg/day; maintenance: 1-4 mg/kg/ay. Other conditions:Adults and children - 1-3 mg/kg/day. If the patient continues to take the medication for 3 months without any improvement in symptoms, discontinuation may be considered.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to azathioprine or 6-mercaptopurine (6-MP). Pregnant or potentially pregnant patients. Patients with rheumatoid arthritis previously treated with alkylating agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Common: Nausea and vomiting (12%) Serious: Pericarditis, Skin cancer, Pancreatitis, Hypersensitivity, Acute myeloid leukemia, Hematologic toxicity, Leukopenia (Renal transplant, >50%; rheumatoid arthritis, 28%), Leukopenia (Severe), <2500 cells/mm (renal transplant, 16%; rheumatoid arthritis, 5.3%), Macrocytic anemia, Myelodysplastic syndrome, Myelosuppression (5%), Pancytopenia, Thrombocytopenia, Hepatotoxicity (<1%), Lymphoma involves liver, Veno-occlusive disease of the liver, Hypersensitivity reaction, Malignant lymphoma (0.5%), T-cell lymphoma, Hepatosplenic, Progressive multifocal leukoencephalopathy, Adenocarcinoma of lung, Infectious disease (renal transplant, 20%; rheumatoid arthritis, <1%), Neoplastic disease (0.5-11.9%) |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

## Imuran 50mg

| TAH Drug Code      | [OIMU](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OIMU)                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | As an adjunct for the prevention of rejection in renal homotransplantation. Treatment of SLE, severe RA, acute & chronic leukemia.                                                                                                                                                                                                                  |
| Dosing             | Adult Transplantation initial dose 5 mg/kg/day, maintenance dose 1-4 mg/kg/day. Other conditions 1-3 mg/kg/day.                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to 6-mercaptopurine. Pregnancy or patients who are likely to become pregnant in the near future.                                                                                                                                                                                                                                   |
| Adverse Effects    | Hypersensitivity reactions; dose-related, reversible bone marrow depression expressed as leucopenia, anemia or thrombocytopenia. Susceptibility to infection especially in transplant recipients. GI reactions, nausea, colitis, diverticulitis, bowel perforation, cholestasis, deterioration of liver function, reversible pneumonitis. Alopecia. |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                       |

